Key result
AI enhances remote cardiac device monitoring, but data and regulatory barriers limit clinical adoption.
Why the study?
The exponential growth in data from remote monitoring of cardiac implantable electronic devices has created alert fatigue and information overload, necessitating advanced data interpretation methods such as AI.
AI holds transformative potential to reshape remote monitoring of cardiac devices into an active, predictive system, provided clinical and technical stakeholders collaborate to overcome existing data and regulatory barriers.
AI-enhanced remote CIED monitoring should not yet change practice; leaves open need for validation addressing data and regulatory barriers.
Remote monitoring of Cardiac Implantable Electronic Devices (CIEDs) has evolved significantly from early trans-telephonic transmissions to now becoming a standard of care that improves survival and outcomes. However, the resulting exponential growth in data has resulted in alert fatigue and information overload, creating a need for advanced data interpretation. This narrative review examines the transformative role of Artificial Intelligence (AI) in reshaping remote monitoring and cardiac device management into an active, predictive, and personalised system. We examine the role of AI across all cardiac implantable electronic devices, including implantable loop recorders (ILRs), pacemakers, implantable cardioverter-defibrillators (ICDs) and cardiac resynchronisation therapy (CRT) devices. We address four questions: (1) the scale and nature of the remote monitoring burden; (2) the AI tools in current clinical use, particularly for ILRs, where alert burden is greatest; (3) AI applications evaluated but not yet widely implemented, including prediction of ventricular arrhythmias, heart failure events and device failure; and (4) future directions, including adaptive device programming and digital twins. While AI demonstrates significant potential to enhance clinical decision-making and patient outcomes, its widespread adoption remains constrained by barriers regarding data quality, algorithm transparency, regulatory compliance, and privacy protections. Realising the full potential of AI in electrophysiology will require sustained collaboration between clinical and technical stakeholders to ensure these tools are deployed effectively and safely.
No takes yet. Share an insight, caveat, or question.
Shahmohamadi et al. (2026) conducted a review in Patients with Cardiac Implantable Electronic Devices (CIEDs). Artificial Intelligence was evaluated. Artificial intelligence demonstrates significant potential to enhance clinical decision-making in remote monitoring of cardiac devices, though adoption is constrained by data and regulatory barriers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: